Regeneron (REGN) Reports Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. PRIM
3. DFTX
4. IBM
5. META
6. MU
7. DPZ
8. ACN
9. ZENA
10. CNC

Go back to Regeneron (REGN) Reports Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthma
Regeneron (NASDAQ: REGN) Delayed: 612.50 --0 (-0%)
Previous Close $612.50    52 Week High $592.36 
Open $612.50    52 Week Low $325.35 
Day High $612.50    P/E 160.76 
Day Low $612.50    EPS $3.81 
Volume 851